BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Overview Fund Activity
Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

328 hedge funds and large institutions have $8.76B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q2 according to their latest regulatory filings, with 109 funds opening new positions, 98 increasing their positions, 98 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
328
Holders Change
+23
Holders Change %
+7.54%
% of All Funds
5.55%
Holding in Top 10
30
Holding in Top 10 Change
+20
Holding in Top 10 Change %
+200%
% of All Funds
0.51%
New
109
Increased
98
Reduced
98
Closed
80
Calls
$86.5M
Puts
$47.5M
Net Calls
+$39M
Net Calls Change
+$17.6M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$443M
2
FCM
Farallon Capital Management
California
$284M
3
UOC
UBS O'Connor
Illinois
$283M
4
PCM
Pentwater Capital Management
Florida
$208M
5
SFM
Soros Fund Management
New York
$183M

Top Sellers

1
Capital World Investors
Capital World Investors
California
$385M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
$157M
3
Fidelity Investments
Fidelity Investments
Massachusetts
$17.1M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
$133M
5
Capital International Investors
Capital International Investors
California
$222M
Name Holding Trade Value Shares
Change 		Shares
Change %
UWM
326
Urban Wealth Management
California
$1K +$1K +10 New
SFG
327
Steward Financial Group
Texas
$1K +$1K +12 New
PCH
328
Polar Capital Holdings
United Kingdom
– -$147K -1,236,609 Closed
APM
329
Avidity Partners Management
Texas
– -$146M -1,231,000 Closed
Viking Global Investors
330
Viking Global Investors
Connecticut
– -$115M -966,139 Closed
Holocene Advisors
331
Holocene Advisors
New York
– -$80.5M -679,238 Closed
Thrivent Financial for Lutherans
332
Thrivent Financial for Lutherans
Minnesota
– -$62.3M -525,010 Closed
AC
333
Armistice Capital
New York
– -$62.1M -524,000 Closed
Fisher Asset Management
334
Fisher Asset Management
Washington
– -$43.7M -368,257 Closed
EAM
335
Eagle Asset Management
Florida
– -$37.7M -318,354 Closed
EAM
336
EULAV Asset Management
Florida
– -$21.9M -185,000 Closed
GCM
337
Glenview Capital Management
New York
– -$18.8M -158,301 Closed
SC
338
Samlyn Capital
New York
– -$18.3M -154,706 Closed
GGHC
339
Gilder Gagnon Howe & Co
New York
– -$17.1M -144,476 Closed
KCM
340
Kingdon Capital Management
New York
– -$16.2M -136,306 Closed
RPAM
341
Rhenman & Partners Asset Management
Sweden
– -$16.1M -136,000 Closed
IBT
342
International Biotechnology Trust
United Kingdom
– -$9.29M -130,900 Closed
CM
343
Caption Management
Oklahoma
– -$10.9M -91,500 Closed
LCG
344
Lisanti Capital Growth
New York
– -$9.01M -75,947 Closed
IC
345
Ikarian Capital
Texas
– -$7.11M -60,000 Closed
WCM Investment Management
346
WCM Investment Management
California
– -$6.74M -56,823 Closed
Axa
347
Axa
France
– -$6.6M -55,656 Closed
CM
348
Castleark Management
Illinois
– -$6.46M -54,440 Closed
Alyeska Investment Group
349
Alyeska Investment Group
Illinois
– -$6.23M -52,500 Closed
TLP
350
Tri Locum Partners
New York
– -$6.14M -51,750 Closed
12 13
14
15 16